Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Jane Gallagher

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cell Metabolism|April 5, 2011
Is growth hormone resistance/IGF-1 reduction good for you?Emily Jane Gallagher, Derek LeRoith
Current Diabetes Reports|April 29, 2010
Insulin, insulin resistance, obesity, and cancerEmily Jane Gallagher, Derek LeRoith
Annals of the New York Academy of Sciences|January 4, 2012
Diabetes, cancer, and metformin: connections of metabolism and cell proliferationEmily Jane Gallagher, Derek LeRoith
Trends in Endocrinology and Metabolism: TEM|July 29, 2010
The proliferating role of insulin and insulin-like growth factors in cancerEmily Jane Gallagher, Derek LeRoith
Physiological Reviews|June 19, 2015
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related MortalityEmily Jane Gallagher, Derek LeRoith
Endocrinology and Metabolism Clinics of North America|March 4, 2014
Diabetes and cancerZara Zelenko, Emily Jane Gallagher
The Medical Clinics of North America|August 23, 2011
The metabolic syndrome--from insulin resistance to obesity and diabetesEmily Jane Gallagher, Derek Leroith, Eddy Karnieli
Endocrinology and Metabolism Clinics of North America|September 9, 2008
The metabolic syndrome--from insulin resistance to obesity and diabetesEmily Jane Gallagher, Derek LeRoith, Eddy Karnieli
Journal of Diabetes|October 7, 2010
Review of hemoglobin A(1c) in the management of diabetesEmily Jane Gallagher, Derek Le Roith, Zachary Bloomgarden
Frontiers in Oncology|February 19, 2021
Obesity, Type 2 Diabetes, and Cancer RiskTiffany Scully, Abora Ettela, Derek LeRoith, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cell Metabolism|April 5, 2011
Is growth hormone resistance/IGF-1 reduction good for you?Emily Jane Gallagher, Derek LeRoith
Current Diabetes Reports|April 29, 2010
Insulin, insulin resistance, obesity, and cancerEmily Jane Gallagher, Derek LeRoith
Annals of the New York Academy of Sciences|January 4, 2012
Diabetes, cancer, and metformin: connections of metabolism and cell proliferationEmily Jane Gallagher, Derek LeRoith
Trends in Endocrinology and Metabolism: TEM|July 29, 2010
The proliferating role of insulin and insulin-like growth factors in cancerEmily Jane Gallagher, Derek LeRoith
Physiological Reviews|June 19, 2015
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related MortalityEmily Jane Gallagher, Derek LeRoith
Endocrinology and Metabolism Clinics of North America|March 4, 2014
Diabetes and cancerZara Zelenko, Emily Jane Gallagher
The Medical Clinics of North America|August 23, 2011
The metabolic syndrome--from insulin resistance to obesity and diabetesEmily Jane Gallagher, Derek Leroith, Eddy Karnieli
Endocrinology and Metabolism Clinics of North America|September 9, 2008
The metabolic syndrome--from insulin resistance to obesity and diabetesEmily Jane Gallagher, Derek LeRoith, Eddy Karnieli
Journal of Diabetes|October 7, 2010
Review of hemoglobin A(1c) in the management of diabetesEmily Jane Gallagher, Derek Le Roith, Zachary Bloomgarden
Frontiers in Oncology|February 19, 2021
Obesity, Type 2 Diabetes, and Cancer RiskTiffany Scully, Abora Ettela, Derek LeRoith, et al.
Pageof 3